Browsing by Author Klebe, Sonja

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 20
Issue DateTitleAuthor(s)Citation
2012Aquaporin 1 is an independent prognostic factor in pleural malignant mesotheliomaKao, Steven; McCaughan, Brian; Armstrong, Nicola; Condon, Bridget; Griggs, Kim; Henderson, Douglas W; Klebe, Sonja; Maltby, Sarah; Wilson, Alan; Concord Clinical School: Medicine; Central Clinical School: SurgeryAquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma, Cancer, vol.118, 11, 2012,pp 2952-2961
2012Association of Genetic Variants in the TMCO1 Gene with Clinical Parameters Related to Glaucoma and Characterization of the Protein in the EyeMitchell, Paul; Burdon, Kathryn P; Casson, Robert; Chidlow, Glyn; Craig, Jamie E.; Crawford, April; Danoy, Patrick; Dave, Alpana; Dimasi, David P; Griggs, Kim; Hewitt, Alex; Javadiyan, Shahrbanou; Klebe, Sonja; Landers, John; Mackey, David A.; Martin, Sarah; Sharma, Shiwani; Wood, John P M; Western Clinical School: Westmead Millennium InstituteAssociation of Genetic Variants in the TMCO1 Gene with Clinical Parameters Related to Glaucoma and Characterization of the Protein in the Eye, Investigative Ophthalmology and Visual Science, vol.53, 8, 2012,pp 4917-4925
2015Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo modelReid, Glen; Cheng, Yuen; Driml, Jack; Griggs, Kim; Henderson, Douglas; Klebe, Sonja; Concord Clinical School: MedicineBlockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model, Disease Markers, vol.2015, N/A, 2015,pp 1-9
2009Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodiesLeigh, James; Henderson, Douglas W; Klebe, Sonja; Nurminen, Markku; School of Public Health: Public HealthDiagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies, Pathology, vol.41, 2,pp 140-148
2014Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesotheliomaClarke, Stephen; Harvie, Rozelle; Howell, Viive; Hudson, Amanda; Moon, Elizabeth; Pavlakis, Nick; Weir, Christopher; Klebe, Sonja; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: MedicineEstablishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma, Scientific Reports, vol.4, N/A, 2014,pp 1-11
2013Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With MesotheliomaClarke, Stephen; Kao, Steven; van Zandwijk, Nico; Vardy, Janette; Henderson, Douglas; Klebe, Sonja; Lee, Kenneth; McCaughan, Brian; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineExcision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma, Clinical Lung Cancer, vol.14, 2, 2013,pp 164-171
2013Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature reviewClarke, Stephen; Kao, Steven; Linton, Anthony; van Zandwijk, Nico; Vardy, Janette; Klebe, Sonja; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineImmunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature review, Asia Pacific Journal of Clinical Oncology, vol.9, 3, 2013,pp 273-279
2012Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural MesotheliomaCheng, Victoria (Yuen); Edelman, John (James); Kao, Steven; Kirschner, Michaela; McCaughan, Brian; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Armstrong, Nicola; Badrian, Bahareh; Creaney, Jenette; Klebe, Sonja; Musk, A. W.; Mutsaers, Steven; Robinson, Bruce W.S.; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteIncreased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, vol.7, 7, 2012,pp 1184-1191
2016KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaCheng, Victoria Yuen Yee; Edelman, John (James); Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Williams, Marissa; Kirschner, Michaela B; Klebe, Sonja; Leshchynska, Iryna; Lin, Ruby C. Y.; McCaughan, Brian; Sarun, Kadir; Sytnyk, Vladimir; Wright, Casey; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research InstituteKCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma, Molecular Cancer, vol.15, 1, 2016,pp 1-12
2016KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaCheng, Victoria Yuen Yee; Edelman, John (James); Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Williams, Marissa; Kirschner, Michaela B; Klebe, Sonja; Leshchynska, Iryna; Lin, Ruby C. Y.; McCaughan, Brian; Sarun, Kadir; Sytnyk, Vladimir; Wright, Casey; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research InstituteKCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma, Molecular Cancer, vol.15, 1, 2016,pp 1-12
2013Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)Cheng, Yuen (Dennis); Kirschner, Michaela; Reid, Glen; van Zandwijk, Nico; Wright, Casey; Schelch, Karin; Gray, Steven; Hoda, Mir; Klebe, Sonja; McCaughan, Brian; O’Byrne, Kenneth; Chemistry; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; School of Medical Sciences: Biomedical SciencesLong Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM), PLoS One, vol.8, 8, 2013,pp 1-12
2011Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural PneumonectomyChatfield, Mark; Clarke, Stephen; Kao, Steven; McCaughan, Brian; Reid, Glen; van Zandwijk, Nico; Vardy, Janette; Armstrong, Nicola; Henderson, Douglas W; Klebe, Sonja; Yan, Tristan; Clinical Schools; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineLow Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy, Journal of Thoracic Oncology, vol.6, 11, 2011,pp 1923-1929
2015miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaCooper, Wendy Anne; Edelman, John (James); Hanh, Jacky; Kao, Steven; Kirschner, Michaela; Linton, Anthony; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Amaro-Mugridge, Nancy; Brahmbhatt, Himanshu; Cheng, YuenYee; Klebe, Sonja; Lin, Ruby C. Y.; MacDiarmid, Jennifer; McCaughan, Brian; Weiss, Jocelyn; Williams, Marissa; Wright, Casey; Central Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstitutemiR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma, Oncotarget, vol.6, 27, 2015,pp 23480-23495
2015MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesotheliomaArmstrong, Nicola Joy; Cheng, Yuen Yee; Kao, Steven; Kirschner, Michaela; Lin, Ruby; Linton, Anthony; McCaughan, Brian; Reid, Glen; van Zandwijk, Nico; Klebe, Sonja; Mathematics & Statistics; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Molecular Bioscience; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteMiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma, Molecular Oncology, vol.9, N/A, 2015,pp 715-726
2013Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant MesotheliomaCheng, Yuen Yee; Reid, Glen; Baltic, Svetlana; Cheah, Hui Min; Klebe, Sonja; Lim, Chuan Bian; Mutsaers, Steven; Prele, Cecilia; Thompson, Philip J.; Watkins, D. Neil; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: MedicineMutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma, PLoS One, vol.8, 6, 2013,pp 1-12
2010Novel quantitative trait loci for central corneal thickness identified by candidate gene analysis of osteogenesis imperfecta genes.Healey, Paul; Mitchell, Paul (Ronald); Burdon, Kathryn P; Chen, Jern; Craig, Jamie E.; Davey, Richard; Dimasi, David P; Forbes, Robin; Hewitt, Alex W.; Klebe, Sonja; Mackey, David A.; Savarirayan, Ravi; Stirling, John; Tan, T; Thompson, Elizabeth; Western Clinical School: Clinical Ophthal & Eye Health; Western Clinical School: Westmead Millennium InstituteNovel quantitative trait loci for central corneal thickness identified by candidate gene analysis of osteogenesis imperfecta genes., Human Genetics, vol.127, 1,pp 33-44
2014An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesotheliomaCheng, Yuen Yee; Gattani, S; Kao, Steven; Kirschner, Michaela; Linton, Anthony; McCaughan, Brian; Reid, Glen; Srikaran, Subothini; van Zandwijk, Nico; Griggs, Kim; Klebe, Sonja; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: ANZAC Research InstituteAn RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma, British Journal of Cancer, vol.110, 2, 2014,pp 510-519
2017Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural MesotheliomaBoyer, Michael; Cheng, Yuen Yee; Cooper, Wendy Anne; Kao, Steven; Kirschner, Michaela; Madore, Jason; McCaughan, Brian; Reid, Glen; Scolyer, Richard; van Zandwijk, Nico; Williams, Marissa; Klebe, Sonja; Linton, Anthony; Lum, Trina; Sarun, Kadir; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Pathology; Concord Clinical School: Medicine; Concord Clinical School: Asbestos Disease Research InstituteTumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, vol.12, 9, 2017,pp 1421-1433
2011Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesotheliomaClarke, Stephen; Kao, Steven; McCaughan, Brian; van Zandwijk, Nico; Vardy, Janette; Armstrong, Nicola; Burn, Juliet; Griggs, Kim; Henderson, Douglas W; Klebe, Sonja; Lee, Kenneth; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineValidation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma, Pathology, vol.43, 4, 2011,pp 313-317
2013ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural MesotheliomaCheng, Ngan Ching; Cheng, Yuen Yee; Edelman, John (James); Gattani, S; Kirschner, Michaela; McCaughan, Brian; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Jin, Hong Chuan; Klebe, Sonja; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Central Clinical School: Surgery; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, vol.8, 10, 2013,pp 1317-1328